{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:01:16Z","timestamp":1793628076121,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National key Research and development program of China","award":["2017YFC09007703"],"award-info":[{"award-number":["2017YFC09007703"]}]},{"name":"science and technology planning project in Sichuan Province","award":["2020YJ0281"],"award-info":[{"award-number":["2020YJ0281"]}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence West China Hospital Sichuan University","award":["ZYJC18038"],"award-info":[{"award-number":["ZYJC18038"]}]},{"name":"cadres health care project in Sichuan Province","award":["2019-112"],"award-info":[{"award-number":["2019-112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Platelets are the primary peripheral reserve of amyloid precursor protein (APP), providing more than 90% of blood amyloid-beta (A\u03b2). Some oxidative stress markers and neurotransmitter markers were also differentially expressed in the peripheral platelets of AD. Therefore, the present study explored the differences in platelet-associated biomarkers between AD and healthy controls using meta-analysis and systematic review to reveal the value of platelet in the pathogenesis and development of AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched all the related studies that probed into the platelets in AD based on PubMed, Embase, and web of science databases from the establishment to November 04, 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty-eight studies were included in the meta-analysis, and the platelets data of 702 AD and 710 controls were analyzed. The results of standardized mean difference (SMD) showed that platelets in AD had lower levels of APP ratio (SMD: -1.89;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), ADAM10 (SMD: -1.16;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), Na\u2009+\u2009-K\u2009+\u2009-ATPase (SMD: -7.23;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), but higher levels of HMW\/LMW tau (SMD: 0.92;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), adenosine A\n                      <jats:sub>2<\/jats:sub>\n                      receptor (SMD: 4.27;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), MAO-B (SMD: 1.73;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), NO (SMD: 4.25;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and ONOO\n                      <jats:sup>\u2212<\/jats:sup>\n                      (SMD: 7.33;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In the systematic review, some other platelet markers seem to be meaningful in AD patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results of the present meta-analysis and systematic review demonstrated that the alterations of APP metabolic enzymes, oxidative stress markers, and neurotransmitter factors in platelets were similar to their changes in the central nervous system of AD, suggesting that platelet could be a good source of peripheral biomarkers and may play an important role in the pathophysiological development of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03099-5","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:04:02Z","timestamp":1676073842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiajia","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"3099_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12877-016-0303-5","volume":"16","author":"NY Kirson","year":"2016","unstructured":"Kirson NY, Desai U, Ristovska L, et al. Assessing the economic burden of Alzheimer\u2019s disease patients first diagnosed by specialists. BMC Geriatr. 2016;16:138. https:\/\/doi.org\/10.1186\/s12877-016-0303-5. (Published 2016 July 11).","journal-title":"BMC Geriatr"},{"key":"3099_CR2","volume-title":"Alzheimer's Disease International","author":"C Patterson","year":"2018","unstructured":"Patterson C. Alzheimer\u2019s Disease International. London: World Alzheimer report; 2018."},{"issue":"23","key":"3099_CR3","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1038\/sj.emboj.7600860","volume":"24","author":"C Reinhard","year":"2005","unstructured":"Reinhard C, H\u00e9bert SS, De Strooper B. The amyloid-beta precursor protein: integrating structure with biological function. EMBO J. 2005;24(23):3996\u20134006. https:\/\/doi.org\/10.1038\/sj.emboj.7600860.","journal-title":"EMBO J"},{"issue":"1\u20132","key":"3099_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2005.09.002","volume":"240","author":"K Tang","year":"2006","unstructured":"Tang K, Hynan LS, Baskin F, Rosenberg RN. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer\u2019s disease. J Neurol Sci. 2006;240(1\u20132):53\u20138. https:\/\/doi.org\/10.1016\/j.jns.2005.09.002.","journal-title":"J Neurol Sci"},{"issue":"3","key":"3099_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/15622970701535502","volume":"9","author":"BS Diniz","year":"2008","unstructured":"Diniz BS, Pinto J\u00fanior JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer\u2019s disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry. 2008;9(3):172\u201382. https:\/\/doi.org\/10.1080\/15622970701535502.","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"3099_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-007-0748-5","volume":"192","author":"IA Zainaghi","year":"2007","unstructured":"Zainaghi IA, Forlenza OV, Gattaz WF. Abnormal APP processing in platelets of patients with Alzheimer\u2019s disease: correlations with membrane fluidity and cognitive decline. Psychopharmacol. 2007;192(4):547\u201353. https:\/\/doi.org\/10.1007\/s00213-007-0748-5.","journal-title":"Psychopharmacol"},{"issue":"7","key":"3099_CR7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11064-013-1039-7","volume":"38","author":"P Bermejo-Besc\u00f3s","year":"2013","unstructured":"Bermejo-Besc\u00f3s P, Mart\u00edn-Arag\u00f3n S, Jim\u00e9nez-Aliaga K, et al. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI). Neurochem Res. 2013;38(7):1415\u201323. https:\/\/doi.org\/10.1007\/s11064-013-1039-7.","journal-title":"Neurochem Res"},{"issue":"10","key":"3099_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/archpsyc.1988.01800340011001","volume":"45","author":"GS Zubenko","year":"1988","unstructured":"Zubenko GS, Huff FJ, Beyer J, Auerbach J, Teply I. Familial risk of dementia associated with a biologic subtype of Alzheimer\u2019s disease. Arch Gen Psychiatry. 1988;45(10):889\u201393. https:\/\/doi.org\/10.1001\/archpsyc.1988.01800340011001.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"3099_CR9","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.neurobiolaging.2006.05.010","volume":"28","author":"A Vignini","year":"2007","unstructured":"Vignini A, Nanetti L, Moroni C, et al. Modifications of platelet from Alzheimer disease patients: a possible relation between membrane properties and NO metabolites. Neurobiol Aging. 2007;28(7):987\u201394. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.05.010.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"3099_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1021\/tx960130e","volume":"10","author":"DA Butterfield","year":"1997","unstructured":"Butterfield DA. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer\u2019s disease. Chem Res Toxicol. 1997;10(5):495\u2013506. https:\/\/doi.org\/10.1021\/tx960130e.","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"3099_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2004.08.011","volume":"26","author":"EM Kawamoto","year":"2005","unstructured":"Kawamoto EM, Munhoz CD, Glezer I, et al. Oxidative state in platelets and erythrocytes in aging and Alzheimer\u2019s disease. Neurobiol Aging. 2005;26(6):857\u201364. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.08.011.","journal-title":"Neurobiol Aging"},{"key":"3099_CR12","first-page":"183","volume":"89","author":"Jie Yu","year":"2009","unstructured":"Yu Jie, Jia Jian-ping. Platelet function in patients with Alzheimer disease: analysis of 40 cases. Zhonghua Yi Xue Za Zhi. 2009;89:183\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"3099_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neuropsychologia.2004.06.007","volume":"43","author":"M Garcia-Alloza","year":"2005","unstructured":"Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, et al. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer\u2019s disease. Neuropsychologia. 2005;43(3):442\u20139. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2004.06.007.","journal-title":"Neuropsychologia"},{"issue":"1\u20132","key":"3099_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0531-5565(02)00158-4","volume":"38","author":"M Racchi","year":"2003","unstructured":"Racchi M, Govoni S. The pharmacology of amyloid precursor protein processing. Exp Gerontol. 2003;38(1\u20132):145\u201357. https:\/\/doi.org\/10.1016\/s0531-5565(02)00158-4.","journal-title":"Exp Gerontol"},{"issue":"3","key":"3099_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00006842-200005000-00006","volume":"62","author":"A Camacho","year":"2000","unstructured":"Camacho A, Dimsdale JE. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med. 2000;62(3):326\u201336. https:\/\/doi.org\/10.1097\/00006842-200005000-00006.","journal-title":"Psychosom Med"},{"key":"3099_CR16","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: URL: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm [cited 2009 Oct 19]"},{"issue":"3","key":"3099_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3233\/JAD-170253","volume":"59","author":"Y Shi","year":"2017","unstructured":"Shi Y, Gu L, Alsharif AA, Zhang Z. The Distinction of Amyloid-\u03b2 Protein Precursor (A\u03b2PP) Ratio in Platelet Between Alzheimer\u2019s Disease Patients and Controls: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2017;59(3):1037\u201344. https:\/\/doi.org\/10.3233\/JAD-170253.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3099_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jnr.10745","volume":"74","author":"G Evin","year":"2003","unstructured":"Evin G, Zhu A, Holsinger RM, Masters CL, Li QX. Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein in brain and platelets. J Neurosci Res. 2003;74(3):386\u201392. https:\/\/doi.org\/10.1002\/jnr.10745.","journal-title":"J Neurosci Res"},{"issue":"10","key":"3099_CR19","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1212\/wnl.54.10.1907","volume":"54","author":"F Baskin","year":"2000","unstructured":"Baskin F, Rosenberg RN, Iyer L, Hynan L, Cullum CM. Platelet APP isoform ratios correlate with declining cognition in AD. Neurology. 2000;54(10):1907\u20139. https:\/\/doi.org\/10.1212\/wnl.54.10.1907.","journal-title":"Neurology"},{"issue":"3","key":"3099_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/s0006-291x(02)02635-9","volume":"299","author":"SJ Tyler","year":"2002","unstructured":"Tyler SJ, Dawbarn D, Wilcock GK, Allen SJ. alpha- and beta-secretase: profound changes in Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2002;299(3):373\u20136. https:\/\/doi.org\/10.1016\/s0006-291x(02)02635-9.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"3099_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000345983","volume":"35","author":"PR Manzine","year":"2013","unstructured":"Manzine PR, de Fran\u00e7a Bram JM, Barham EJ, et al. ADAM10 as a biomarker for Alzheimer\u2019s disease: a study with Brazilian elderly. Dement Geriatr Cogn Disord. 2013;35(1\u20132):58\u201366. https:\/\/doi.org\/10.1159\/000345983.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Pt 5","key":"3099_CR22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1042\/BST20051096","volume":"33","author":"JA Johnston","year":"2005","unstructured":"Johnston JA, Liu WW, Todd SA, et al. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer\u2019s disease. Biochem Soc Trans. 2005;33(Pt 5):1096\u2013100. https:\/\/doi.org\/10.1042\/BST20051096.","journal-title":"Biochem Soc Trans"},{"issue":"1\u20132","key":"3099_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nbd.2005.01.002","volume":"19","author":"M Zimmermann","year":"2005","unstructured":"Zimmermann M, Borroni B, Cattabeni F, Padovani A, Di Luca M. Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients. Neurobiol Dis. 2005;19(1\u20132):237\u201342. https:\/\/doi.org\/10.1016\/j.nbd.2005.01.002.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"3099_CR24","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","volume":"59","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol. 2002;59(9):1381\u20139. https:\/\/doi.org\/10.1001\/archneur.59.9.1381.","journal-title":"Arch Neurol"},{"issue":"1","key":"3099_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2009.08.004","volume":"45","author":"B Borroni","year":"2010","unstructured":"Borroni B, Agosti C, Marcello E, Di Luca M, Padovani A. Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol. 2010;45(1):53\u20136.","journal-title":"Exp Gerontol"},{"issue":"12","key":"3099_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/membranes11120983","volume":"11","author":"X Liu","year":"2021","unstructured":"Liu X, Liu Y, Ji S. Secretases Related to Amyloid Precursor Protein Processing. Membranes (Basel). 2021;11(12):983. https:\/\/doi.org\/10.3390\/membranes11120983. (Published 2021 Dec 15).","journal-title":"Membranes (Basel)."},{"issue":"8","key":"3099_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00406-018-0905-3","volume":"269","author":"JMF Bram","year":"2019","unstructured":"Bram JMF, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN-1 in platelets and leukocytes of Alzheimer\u2019s disease patients. Eur Arch Psychiatry Clin Neurosci. 2019;269(8):963\u201372. https:\/\/doi.org\/10.1007\/s00406-018-0905-3.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"3099_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","volume":"41","author":"RB Maccioni","year":"2010","unstructured":"Maccioni RB, Far\u00edas G, Morales I, Navarrete L. The revitalized tau hypothesis on Alzheimer\u2019s disease. Arch Med Res. 2010;41(3):226\u201331. https:\/\/doi.org\/10.1016\/j.arcmed.2010.03.007.","journal-title":"Arch Med Res"},{"issue":"1","key":"3099_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JAD-2012-120304","volume":"31","author":"G Far\u00edas","year":"2012","unstructured":"Far\u00edas G, P\u00e9rez P, Slachevsky A, Maccioni RB. Platelet tau pattern correlates with cognitive status in Alzheimer\u2019s disease. J Alzheimers Dis. 2012;31(1):65\u20139. https:\/\/doi.org\/10.3233\/JAD-2012-120304.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"3099_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/JAD-180637","volume":"67","author":"L Guzm\u00e1n-Mart\u00ednez","year":"2019","unstructured":"Guzm\u00e1n-Mart\u00ednez L, Tapia JP, Far\u00edas GA, Gonz\u00e1lez A, Estrella M, Maccioni RB. The Alz-tau Biomarker for Alzheimer\u2019s Disease: Study in a Caucasian Population. J Alzheimers Dis. 2019;67(4):1181\u20136. https:\/\/doi.org\/10.3233\/JAD-180637.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"3099_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/s0197-4580(03)00005-8","volume":"24","author":"CE Teunissen","year":"2003","unstructured":"Teunissen CE, L\u00fctjohann D, von Bergmann K, et al. Combination of serum markers related to several mechanisms in Alzheimer\u2019s disease. Neurobiol Aging. 2003;24(7):893\u2013902. https:\/\/doi.org\/10.1016\/s0197-4580(03)00005-8.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"3099_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jat.922","volume":"23","author":"P Muriel","year":"2003","unstructured":"Muriel P, Casta\u00f1eda G, Ortega M, No\u00ebl F. Insights into the mechanism of erythrocyte Na+\/K+-ATPase inhibition by nitric oxide and peroxynitrite anion. J Appl Toxicol. 2003;23(4):275\u20138. https:\/\/doi.org\/10.1002\/jat.922.","journal-title":"J Appl Toxicol"},{"issue":"2\u20133","key":"3099_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","volume":"130","author":"S Varadarajan","year":"2000","unstructured":"Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Alzheimer\u2019s amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol. 2000;130(2\u20133):184\u2013208. https:\/\/doi.org\/10.1006\/jsbi.2000.4274.","journal-title":"J Struct Biol"},{"issue":"12","key":"3099_CR34","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A, et al. Role of Monoamine Oxidase Activity in Alzheimer\u2019s Disease: An Insight into the Therapeutic Potential of Inhibitors. Molecules. 2021;26(12):3724. https:\/\/doi.org\/10.3390\/molecules26123724. (Published 2021 Jun 18).","journal-title":"Molecules."},{"key":"3099_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pnpbp.2016.02.005","volume":"69","author":"RR Ramsay","year":"2016","unstructured":"Ramsay RR. Molecular aspects of monoamine oxidase B. Prog Neuropsychopharmacol Biol Psychiatry. 2016;69:81\u20139. https:\/\/doi.org\/10.1016\/j.pnpbp.2016.02.005.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"3099_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0161-813X(03)00115-3","volume":"25","author":"L Oreland","year":"2004","unstructured":"Oreland L. Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology. 2004;25(1\u20132):79\u201389. https:\/\/doi.org\/10.1016\/S0161-813X(03)00115-3.","journal-title":"Neurotoxicology"},{"issue":"3","key":"3099_CR37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pharmacology of Adenosine Receptors: The State of the Art. Physiol Rev. 2018;98(3):1591\u2013625. https:\/\/doi.org\/10.1152\/physrev.00049.2017.","journal-title":"Physiol Rev"},{"issue":"47","key":"3099_CR38","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","volume":"29","author":"PM Canas","year":"2009","unstructured":"Canas PM, Porci\u00fancula LO, Cunha GM, et al. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci. 2009;29(47):14741\u201351. https:\/\/doi.org\/10.1523\/JNEUROSCI.3728-09.2009.","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"3099_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","volume":"20","author":"JJ Lucas","year":"2001","unstructured":"Lucas JJ, Hern\u00e1ndez F, G\u00f3mez-Ramos P, Mor\u00e1n MA, Hen R, Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 2001;20(1\u20132):27\u201339. https:\/\/doi.org\/10.1093\/emboj\/20.1.27.","journal-title":"EMBO J"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03099-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03099-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03099-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T06:07:32Z","timestamp":1676268452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03099-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03099-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no ethical issues involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}